6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol

Catalog No.: 
ACXZWP754
CAS No.: 
117098-94-9
Molecular Formula: 
C7H8BNO2
Molecular Weight: 
148.96
6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$103.00In stockIn stock
5g98%$480.00In stockIn stock
25g98%$2328.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol
IUPAC Name6-aminobenzo[c][1,2]oxaborol-1(3H)-ol
MDL No.MFCD14584713
Molecular FormulaC7H8BNO2
Molecular Weight148.96
SMILESNC1=CC2=C(COB2O)C=C1
InChI KeyUSCKQKQTFCBECF-UHFFFAOYSA-N
Synonym6-Amino-3H-2,1-benzoxaborol-1-ol | 6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol | 5-Amino-2-(hydroxymethyl)phenylboronic Acid Cyclic Monoester | 6-Amino-1-hydroxy-2,1-benzoxaborolane | EN300-122818 | 1-hydroxy-3H-2,1-benzoxaborol-6-amine | AKOS016005929 | MFCD14
CAS No.117098-94-9
PubChem CID3770187

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXZWP754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEVGY465 route compound structure diagram
    ACEVGY465118803-40-0In Stock
  2. Then
  3. ACXZWP754 route product structure diagram
    ACXZWP754117098-94-9In Stock
Inquiry

2. ACXZWP754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEVGY465 route compound structure diagram
    ACEVGY465118803-40-0In Stock
  2. Then
  3. ACXZWP754 route product structure diagram
    ACXZWP754117098-94-9In Stock
Inquiry

3. ACXZWP754 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQMCA293 route compound structure diagram
    ACQMCA293850568-79-5In Stock
  2. Then
  3. ACXZWP754 route product structure diagram
    ACXZWP754117098-94-9In Stock
Inquiry

Comments (0)